Literature DB >> 15184474

Utility of reverse transcriptase PCR for rapid diagnosis of influenza a virus infection and detection of amantadine-resistant influenza a virus isolates.

Constance T Pachucki1, M Aijaz Khurshid, John Nawrocki.   

Abstract

A reverse transcriptase PCR was developed to detect 50 or 5,000 RNA copies of influenza A virus per ml in throat swab specimens. The assay was more sensitive than the Directigen Flu A test. The technique was also used to detect amantadine-resistant isolates.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15184474      PMCID： PMC427877          DOI： 10.1128/JCM.42.6.2796-2798.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

1.  Impact of respiratory virus infections on persons with chronic underlying conditions.

Authors:  W P Glezen; S B Greenberg; R L Atmar; P A Piedra; R B Couch
Journal:  JAMA       Date:  2000-01-26       Impact factor: 56.272

2.  Perforin expression in human peripheral blood mononuclear cells. Definition of an IL-2-independent pathway of perforin induction in CD8+ T cells.

Authors:  P Lu; J A Garcia-Sanz; M G Lichtenheld; E R Podack
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

3.  Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis.

Authors:  A I Klimov; E Rocha; F G Hayden; P A Shult; L F Roumillat; N J Cox
Journal:  J Infect Dis       Date:  1995-11       Impact factor: 5.226

4.  Performance of virus isolation and Directigen Flu A to detect influenza A virus in experimental human infection.

Authors:  L Kaiser; M S Briones; F G Hayden
Journal:  J Clin Virol       Date:  1999-12       Impact factor: 3.168

5.  Detection of influenza A and B in respiratory secretions with the polymerase chain reaction.

Authors:  J C Donofrio; J D Coonrod; J N Davidson; R F Betts
Journal:  PCR Methods Appl       Date:  1992-05

6.  Production of the M2 protein of influenza A virus in insect cells is enhanced in the presence of amantadine.

Authors:  R A Black; P A Rota; N Gorodkova; A Cramer; H D Klenk; A P Kendal
Journal:  J Gen Virol       Date:  1993-08       Impact factor: 3.891

7.  Mortality associated with influenza and respiratory syncytial virus in the United States.

Authors:  William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Nancy Cox; Larry J Anderson; Keiji Fukuda
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

8.  Pneumonia and influenza deaths during epidemics: implications for prevention.

Authors:  W H Barker; J P Mullooly
Journal:  Arch Intern Med       Date:  1982-01

9.  Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults.

Authors:  J A Englund; R E Champlin; P R Wyde; H Kantarjian; R L Atmar; J Tarrand; H Yousuf; H Regnery; A I Klimov; N J Cox; E Whimbey
Journal:  Clin Infect Dis       Date:  1998-06       Impact factor: 9.079

10.  Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985.

Authors:  K J Lui; A P Kendal
Journal:  Am J Public Health       Date:  1987-06       Impact factor: 9.308
View more
  10 in total

1.  Rapid Tests for Influenza.

Authors:  Constance T Pachucki
Journal:  Curr Infect Dis Rep       Date:  2005-05       Impact factor: 3.725

2.  Rapid, simple influenza RNA extraction from nasopharyngeal samples.

Authors:  Darrell P Chandler; Sara B Griesemer; Christopher G Cooney; Rebecca Holmberg; Nitu Thakore; Becca Mokhiber; Phillip Belgrader; Christopher Knickerbocker; Jeanmarie Schied; Kirsten St George
Journal:  J Virol Methods       Date:  2012-03-07       Impact factor: 2.014

Review 3.  Amantadine and rimantadine for influenza A in children and the elderly.

Authors:  Márcia G Alves Galvão; Marilene Augusta Rocha Crispino Santos; Antonio J L Alves da Cunha
Journal:  Cochrane Database Syst Rev       Date:  2014-11-21

4.  Aetiology of influenza-like illness in adults includes parainfluenzavirus type 4.

Authors:  Hatice Hasman; Constance T Pachucki; Arife Unal; Diep Nguyen; Troy Devlin; Mark E Peeples; Steven A Kwilas
Journal:  J Med Microbiol       Date:  2009-04       Impact factor: 2.472

5.  Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011.

Authors:  V A Potdar; M R Dakhave; P B Kulkarni; S A Tikhe; S Broor; P Gunashekaran; M Chawla-Sarkar; A Abraham; D Bishwas; K N Patil; A A Kadam; S S Kode; A C Mishra; M S Chadha
Journal:  Indian J Med Res       Date:  2014-08       Impact factor: 2.375

6.  A rapid-response ultrasensitive biosensor for influenza virus detection using antibody modified boron-doped diamond.

Authors:  Dawid Nidzworski; Katarzyna Siuzdak; Paweł Niedziałkowski; Robert Bogdanowicz; Michał Sobaszek; Jacek Ryl; Paulina Weiher; Mirosław Sawczak; Elżbieta Wnuk; William A Goddard; Andrés Jaramillo-Botero; Tadeusz Ossowski
Journal:  Sci Rep       Date:  2017-11-16       Impact factor: 4.379

Review 7.  Clinical Mimics: An Emergency Medicine-Focused Review of Influenza Mimics.

Authors:  Erica Simon; Brit Long; Alex Koyfman
Journal:  J Emerg Med       Date:  2017-02-16       Impact factor: 1.484

Review 8.  Recent Development of Aptasensor for Influenza Virus Detection.

Authors:  Soo Min Kim; Jinmyeong Kim; Seungwoo Noh; Hiesang Sohn; Taek Lee
Journal:  Biochip J       Date:  2020-11-16       Impact factor: 3.494

9.  3D simulation of microfluidic biosensor for SARS-CoV-2 S protein binding kinetics using new reaction surface design.

Authors:  Sameh Kaziz; Yosra Saad; Mohamed Hichem Gazzah; Hafedh Belmabrouk
Journal:  Eur Phys J Plus       Date:  2022-02-18       Impact factor: 3.911

10.  Design parameters optimization of an electrothermal flow biosensor for the SARS-CoV-2 S protein immunoassay.

Authors:  Sameh Kaziz; Ibrahim Ben Mariem; Fraj Echouchene; Mohamed Hichem Gazzah; Hafedh Belmabrouk
Journal:  Indian J Phys Proc Indian Assoc Cultiv Sci (2004)       Date:  2022-04-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.